Ngenla 60 mg – Pfizer – Australia

Description

Ngenla 60 mg – Pfizer – Australia

Ngenla 60 mg – Pfizer – Australia is a once-weekly long-acting growth hormone therapy containing somatrogon designed for the treatment of growth hormone deficiency (GHD) in children and adolescents aged ≥3 years. Unlike traditional daily HGH injections, Ngenla’s extended-release formula supports stable growth and metabolism with fewer injections, improving convenience and compliance. Delivered in a 60 mg prefilled, disposable injection pen with adjustable dosing, it promotes height velocity and normal growth progression when prescribed by a healthcare professional. Requires subcutaneous administration and medical supervision. Prescription only.